News about Drug Discovery & Development

Sun Pharma Launches SEZABY in US to treat neonatal seizures

Sun Pharma Launches SEZABY in US to treat neonatal seizures

This is the first and only FDA Approved product in US to treat neonatal seizures

Drug Discovery & Development | 27/01/2023 | By Sudeep Soparkar

ENTOD Pharma's state-of-the-art R&D facility opens in Navi Mumbai

ENTOD Pharma's state-of-the-art R&D facility opens in Navi Mumbai

The brand new additional R&D facility in Navi Mumbai has been designed with state-of-the-art equipment and the latest analytical & formulation research tools

Drug Discovery & Development | 27/01/2023 | By Sudeep Soparkar

Marksans Pharma announces UK MHRA approval for Fluoxetine 20mg/5ml oral solution

Marksans Pharma announces UK MHRA approval for Fluoxetine 20mg/5ml oral solution

The product will be manufactured at the plant of Bell, Sons & Co, UK

Drug Discovery & Development | 24/01/2023 | By Sudeep Soparkar

Eurofins CDMO Alphora expands API development labs

Eurofins CDMO Alphora expands API development labs

The 56,000-square foot building is the new home of Eurofins CDMO Alphora’s API process R&D activity, solid-state R&D activity and its analytical services team

Drug Discovery & Development | 17/01/2023 | By Sudeep Soparkar

AstraZeneca partners with Australia-based LBT Innovations for new pharma product line

AstraZeneca partners with Australia-based LBT Innovations for new pharma product line

AstraZeneca will fund the development of the APAS Pharma analysis module and validate the final product for their processes
<br />

Drug Discovery & Development | 12/01/2023 | By Sudeep Soparkar

Glenmark Pharma launches Bumetanide Injection in single and multi-dose vials

Glenmark Pharma launches Bumetanide Injection in single and multi-dose vials

The product is the generic version of Bumex 1 Injection, 0.25 mg/mL, of Validus Pharmaceuticals

Drug Discovery & Development | 11/01/2023 | By Sudeep Soparkar

Zydus launches Topiramate extended-release capsules

Zydus launches Topiramate extended-release capsules

Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the US
<br />

Drug Discovery & Development | 07/01/2023 | By Sudeep Soparkar

Asymchem opens R&D site near Boston, Massachusetts

Asymchem opens R&D site near Boston, Massachusetts

The new Boston site is focussed on providing early-stage R&D services including chemical process development, pre-formulation study and formulation development
<br />

Drug Discovery & Development | 20/12/2022 | By Sudeep Soparkar

Freudenberg Medical unveils HelixFlex at CPhI & PMEC India

Freudenberg Medical unveils HelixFlex at CPhI & PMEC India

TPE tubing is ideal for pharmaceutical bioprocessing applications

Drug Discovery & Development | 30/11/2022 | By Sudeep Soparkar

Cipla unveils Leuprolide Acetate Injection Depot 22.5mg

Cipla unveils Leuprolide Acetate Injection Depot 22.5mg

The injection is indicated for the palliative treatment of advanced prostate cancer

Drug Discovery & Development | 29/11/2022 | By Sudeep Soparkar

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology